W. Phakhodee et al. / Tetrahedron 65 (2009) 351–356
355
then slowly added dropwise and the entire reaction mixture was sub-
sequently stirred for different amounts of time (2, 4, 6, 8, 10 and 17 h).
After that, the reaction was quenched with water, neutralised with 25%
NH4OH and the aqueous phase extracted with CH2Cl2 (3ꢂ20 mL). The
combined organic layers were washed with water, brine, dried (Na2SO4),
filtered and the solvent evaporated under reduced pressure to give the
crude product ,which was purified by preparative TLC (60% EtOAc/
hexane) to give the desired isoquinolinobenzazepinone 9b. Similarly,
when H2SO4/AcOH was utilised, concd H2SO4 (1 mL) was employed
instead of concd HCl for 2, 4, 6, 8, 10 and 17 h. When formic acid was
used, compound 6 was refluxed in formic acid (10 mL) for 1 and 2 h.
From all cases, the desired product 9b was obtained from the crude
product by preparative TLC (60% EtOAc/hexanes) as a white solid (see
Table 1 for yields). Mp 185 ꢀC; IR (KBr) nmax 1645, 1521, 1448 cmꢁ1; 1H
CH2CO), 3.81 (s, 3H, OCH3), 3.83 (s, 3H, OCH3), 3.85 (s, 3H, OCH3), 3.91
(s, 3H, OCH3), 4.77 (s, 2H, CH2N), 6.54 (s, 1H, CH]C–N), 6.73 (s, 2H,
ArH), 6.77 (s, 1H, ArH), 7.02 (s, 1H, ArH); 13C NMR (CDCl3, 75 MHz):
d
43.7, 53.1, 55.97, 56.0, 56.2, 102.4, 104.2, 105.4, 109.8, 112.0, 121.7,
127.6,128.4,129.2,139.0,148.2,149.3,149.8,150.7,168.0;LRMS(EI)m/z
(relintensity)369 (Mþþ2,4), 368(MþHþ, 26), 367(Mþ,100), 353(15),
352 (60). Anal.Calcd forC21H21NO5: C, 68.65;H, 5.76;N, 3.81. Found:C,
68.51; H, 5.36; N, 3.52.
4.7. 2,3,10,11-Tetramethoxy-5,8,13,13a-tetrahydrobenzo-
[4,5]azepino[2,1-a]isoindol-7-one (9a)
To a stirred solution of dehydroindolinobenzazepinone 15
(0.05 g, 0.14 mmol) in CH2Cl2 containing AcOH (10 drops), 10% Pd
on charcoal (0.054 g) was added. The mixture was hydrogenated
with a hydrogen balloon at 1 atm by stirring at room temperature
for 20 h. Catalyst residue was removed by filtration and the residue
was washed with CH2Cl2. The organic layer was washed with water,
dried (Na2SO4), filtered and concentrated to give the crude product,
which was purified by preparative TLC (60% EtOAc/hexanes) to
provide isoindolinobenzazepinone 9a (0.042 g, 0.12 mmol, 83%) as
a white solid. Mp 264.0 ꢀC (decomposed); IR (KBr) nmax 1635, 1611,
NMR (CDCl3, 300 MHz):
d
2.85 (t, J¼6.0 Hz, 2H, CH2CH2N), 3.20 (dd,
J¼11.4, 3.5 Hz, 1H, CH2CHN), 3.27 (dd, J¼11.4, 3.5 Hz, 1H, CH2CHN), 3.44
(d, J¼15.0 Hz, 1H, CH2CO), 3.61 (dt, J¼13.0, 6.0 Hz,1H, CH2CH2N), 3.83 (s,
3H, OCH3), 3.87 (s, 3H, OCH3), 3.89 (s, 3H, OCH3), 3.90 (s, 3H, OCH3), 4.03
(dt, J¼13.0, 6.0 Hz, 1H, CH2CH2N), 4.50 (d, J¼15.0 Hz, 1H, CH2CO), 5.43
(dd, J¼11.4, 3.5 Hz, 1H, CH2CHN), 6.57 (s, 1H, ArH), 6.66 (s, 1H, ArH), 6.70
(s,1H, ArH), 6.73 (s,1H, ArH); 13C NMR (CDCl3, 75 MHz):
d 28.1, 37.8, 41.0,
42.6, 54.2, 55.82, 55.85, 55.88, 56.04,109.6,111.2,113.1,114.0,123.0,127.3,
127.7, 147.2, 147.8, 147.9, 148.0, 171.8; LRMS (EI) m/z (rel intensity) 384
(MþHþ, 21), 383 (Mþ, 79), 355 (23), 192 (100), 190 (84). Anal. Calcd for
C22H25NO5: C, 68.91; H, 6.57; N, 3.65. Found: C, 68.88; H, 6.64; N, 3.49.
1523, 1465, 1451, 1433 cmꢁ1; 1H NMR (CDCl3, 300 MHz):
d 3.02 (dd,
J¼16.9, 12.0 Hz, 1H, CH2CHN), 3.40 (d, J¼16.9 Hz, 1H, CH2CHN), 3.46
(d, J¼15.0 Hz, 1H, CH2CO), 3.82 (s, 3H, OCH3), 3.84 (s, 3H, OCH3),
3.91 (s, 3H, OCH3), 3.92 (s, 3H, OCH3), 4.31 (d, J¼15.0 Hz,1H, CH2CO),
4.69 (d, J¼15.4 Hz, 1H, CH2N), 4.85 (d, J¼15.4 Hz, 1H, CH2N), 5.53 (d,
J¼12.0 Hz, 1H, CH2CHN), 6.57 (s, 1H, ArH), 6.64 (s, 1H, ArH), 6.78 (s,
4.5. 2,3,10,11-Tetramethoxy-5,13-dihydro-8H-6,13-
methanodibenzo[c,f]azonin-7-one (11)
1H, ArH), 6.82 (s, 1H, ArH); 13C NMR (CDCl3, 75 MHz):
d 40.7, 43.0,
3-(3,4-Dimethoxybenzyl)-7,8-dimethoxy-1,3-dihydrobenzo
[d]azepin-2-one 10 (0.30 g, 0.81 mmol) was refluxed in triflic acid
(0.30 mL, 3.44 mmol) in CH2Cl2 (5 mL) for 2 h. At that time water
(20 mL) was added and then the mixture was extracted with CH2Cl2
(2ꢂ20 mL). The combined CH2Cl2 layers were washed with 10%
sodium carbonate and water, and dried (Na2SO4). After evaporation
of the solvent, the obtained solid was recrystallised from methanol/
diethyl ether and CH2Cl2 to give colourless needles of tetracycle 11
(0.18 g, 0.49 mmol) in 64% yield. Mp 306 ꢀC (decomposed); IR (KBr)
51.0, 55.81, 55.84, 56.04, 56.10, 61.4, 105.0, 105.7, 113.2, 114.0, 122.6,
126.8, 127.2, 132.0, 147.2, 147.8, 149.2, 149.6, 170.5; LRMS (EI) m/z
(rel intensity) 371 (Mþþ2, 2), 370 (MþHþ, 14), 369 (Mþ, 58), 178
(22), 177 (100), 165 (21). HRMS (TOF) Calcd for C21H24NO5[MþH]þ
370.1649, found: 370.1656.
Acknowledgements
nmax 1656, 1521, 1463 cmꢁ1 1H NMR (CDCl3, 300 MHz):
; d 3.42 (d,
We acknowledge the financial support from the Center for En-
vironmental Health, Toxicology and Management of Toxic Chem-
icals (ETM). One of us (W.P.) acknowledges partial financial support
from Center for Innovation in Chemistry: Postgraduate Education
and Research in Chemistry (CIC-PERCH).
J¼15.0 Hz, 1H, CH2N), 3.69 (dd, J¼14.5, 3.4 Hz, 1H, CHCH2N), 3.83 (s,
6H, 2ꢂOCH3), 3.90 (s, 3H, OCH3), 3.93 (d, J¼3.4 Hz, 1H, CHCH2N),
3.94 (s, 3H, OCH3), 4.07 (d, J¼15.8 Hz, 1H, CH2CO), 4.48 (d,
J¼15.0 Hz, 1H, CH2N), 4.57 (d, J¼14.5 Hz, 1H, CHCH2N), 5.38 (d,
J¼15.8 Hz,1H, CH2CO), 6.56 (s,1H, ArH), 6.60 (s,1H, ArH), 7.02 (s,1H,
ArH), 7.06 (s, 1H, ArH); 13C NMR (CDCl3, 75 MHz):
d 40.3, 42.3, 46.5,
References and notes
47.6, 55.84, 55.88, 55.94, 56.00, 109.2, 112.0, 113.8, 114.7, 122.9, 127.1,
129.6, 132.4, 147.5, 147.6, 147.7, 148.0, 174.9; LRMS (EI) m/z (rel in-
tensity) 370 (MþþHþ, 25), 369 (Mþ, 100), 340 (43), 309 (43), 281
(54). Anal. Calcd for C21H23NO5: C, 68.28; H, 6.28; N, 3.79. Found: C,
68.42; H, 6.52; N, 3.60.
´
1. Valencia, E.; Weiss, I.; Firdous, S.; Freyer, A.; Shamma, M.; Urzua, A.; Fajardo, V.
Tetrahedron 1984, 40, 3957–3962.
2. Rahimizadeh, M. J. Sci., Islamic Repub. Iran 1996, 7, 172–176.
3. Rodrı´guez, G.; Cid, M. M.; Saa´, C.; Castedo, L.; Domı´nguez, D. J. Org. Chem. 1996,
61, 2780–2782.
4. Ishibashi, H.; Kawanami, H.; Ikeda, M. J. Chem. Soc., Perkin Trans. 1 1997, 817–
821.
4.6. 2,3,10,11-Tetramethoxy-5,8,13,13a-tetrahydrobenzo-
[4,5]azepino[2,1-a]isoindol-7-one (15)
5. Taniguchi, T.; Iwasaki, K.; Uchiyama, M.; Tamura, O.; Ishibashi, H. Org. Lett.
2005, 7, 4389–4390.
6. Kim, G.; Kim, J. H.; Kim, W.-J.; Kim, Y. A. Tetrahedron Lett. 2003, 44, 8207–8209.
7. Couty, S.; Meyer, C.; Cossy, J. Tetrahedron Lett. 2006, 47, 767–769.
8. Honda, T.; Sakamaki, Y. Tetrahedron Lett. 2005, 46, 6823–6825.
9. (a) Koseki, Y.; Kusano, S.; Sakata, H.; Nagasaka, T. Tetrahedron Lett. 1999, 40,
2169–2172; (b) Koseki, Y.; Katsura, S.; Kusano, S.; Sakata, H.; Sato, H.; Monzene,
Y.; Nagasaka, T. Heterocycles 2003, 59, 527–540.
10. Fuchs, J. R.; Funk, R. L. Org. Lett. 2001, 3, 3923–3925.
11. Couture, A.; Deniau, E.; Grandclaudon, P.; Hoarau, C. Tetrahedron 2000, 56,
1491–1499.
12. Comins, D. L.; Schilling, S.; Zhang, Y. Org. Lett. 2005, 7, 95–98.
13. Suzuki, T.; Takabe, K.; Yoda, H. Synlett 2006, 3407–3410.
14. Fuwa, H.; Sasaki, M. Org. Biomol. Chem. 2007, 5, 1849–1853.
15. (a) Ruchirawat, S.; Sahakitpichan, P. Tetrahedron Lett. 2000, 41, 8007–8010; (b)
Sahakitpichan, P.; Ruchirawat, S. Tetrahedron 2004, 60, 4169–4172.
16. Suau, R.; Lo´pez-Romero, J. M.; Ruiz, A.; Rico, R. Tetrahedron 2000, 56, 993–998.
17. Reiffen, M.; Eberlien, W.; Mu¨ller, P.; Psiorz, M.; Noll, K.; Heider, J.; Lillie, C.;
Kobinger, W.; Luger, P. J. Med. Chem. 1990, 33, 1496–1504.
A mixture of 3-(2-iodo-4,5-dimethoxybenzyl)-7,8 dimethoxy-1,3-
dihydrobenzo[d]azepin-2-one
8
(0.10 g, 0.20 mmol), Pd(OAc)2
(0.0045 g, 0.02 mmol, 10 mol %), K2CO3 (0.056 g, 0.40 mmol), and
Bu4NþBrꢁ (0.065 g, 0.2 mmol) in dry DMF (10 mL) was heated at
110 ꢀC for 2 h. The reaction mixture was quenched with aq NH4Cl
(10 mL), filtered and the aqueous phase was then extracted with
CH2Cl2 (3ꢂ15 mL). The combined organic layers were washed with
water, dried (Na2SO4), filtered and concentrated under reduced
pressure to dryness. The crude product was purified by preparative
TLC (60%EtOAc/hexanes)to afford dehydroisoindolinobenzazepinone
15 (67 mg, 0.18 mmol, 91%) as a white solid. Mp 214–215 ꢀC; IR (KBr)
nmax 1655, 1608, 1517 cmꢁ1; 1H NMR (CDCl3, 300 MHz):
d 3.46 (s, 2H,